Diffusion Pharmaceuticals... (DFFN)
NASDAQ: DFFN
· Real-Time Price · USD
4.40
0.41 (10.28%)
At close: Aug 16, 2023, 10:00 PM
Diffusion Pharmaceuticals Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -29.07M | -22.02M | -11.9M | -6.37M | -8.13M | -13.08M | -15.16M | -15.59M | -14.99M | -24.39M | -23.98M | -24.1M | -24.68M | -16.92M | -16.27M |
Depreciation & Amortization | 50.58M | 50.58M | n/a | -50.58M | -50.79M | -50.79M | -50.79M | -13.75M | -13.52M | -13.5M | -13.48M | 93.42K | 92.24K | 97.33K | 100.59K |
Stock-Based Compensation | 3.17M | 2.81M | 1.65M | 760.62K | 371.95K | 553.83K | 771.29K | 928.05K | 992.45K | 974.96K | 994.11K | 897.26K | 794.77K | 909.86K | 726.02K |
Other Working Capital | 510.2K | 510.2K | n/a | -582.66K | -230.19K | -51.45K | 253.97K | 413.19K | -69.21K | -75.95K | -327.22K | -249K | 623.31K | 831.66K | 446.52K |
Other Non-Cash Items | -52.34M | -54.6M | -2.33M | 48.26M | 48.38M | 50.57M | 50.54M | n/a | -70.38K | 17.28M | 17.32M | 17.33M | 18.75M | 1.47M | 1.47M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -443.89K | -443.89K | -443.89K | -443.89K | -805.68K | -1.31M |
Change in Working Capital | 2.12M | 2.12M | n/a | -1.54M | -1.04M | -1.1M | -575.93K | -97.16K | -479.57K | 434.33K | 626.79K | 356.37K | 730.34K | 1.31M | 1.53M |
Operating Cash Flow | -23.16M | -17.01M | -8.48M | -5.35M | -8.83M | -13.85M | -15.21M | -14.97M | -14.52M | -14.74M | -14.06M | -14.5M | -14.87M | -15.41M | -15.22M |
Capital Expenditures | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -99.67M | -92.57M | -44.47M | n/a | -31.62M | -37.99M | -46.89M | -69.6M | -37.99M | -31.62M | -22.72M | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | 22.94M | 10.44M | 6.5M | 12.5M | 19.5M | 29.25M | 26.25M | 16.75M | 9.75M | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | 31.62M | 31.62M | 40.62M | 40.62M | 9M | 9M | 4K | 4K | n/a | n/a | n/a |
Investing Cash Flow | -76.73M | -82.13M | -37.97M | 12.5M | 19.5M | 22.88M | 19.98M | -12.24M | -19.23M | -22.61M | -22.71M | 4K | n/a | n/a | n/a |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | 6.99M | 6.99M | 6.99M | 6.99M | 5K | 5K | 5M | 5M | 5M | 5M | 33.3M | 22.47M | 22.33M | 40.2M |
Financial Cash Flow | 78.82M | 85.81M | 46.4M | 6.99M | 6.99M | 5K | 5K | 10K | 5K | 5K | 5K | 33.3M | 33.3M | 33.15M | 51.03M |
Net Cash Flow | -253.18K | 7.49M | 8.1M | 14.14M | 17.66M | 9.03M | 4.77M | -27.2M | -33.75M | -37.34M | -36.76M | 18.8M | 18.42M | 17.75M | 35.81M |
Free Cash Flow | -23.16M | -17.01M | -8.48M | -5.35M | -8.83M | -13.85M | -15.21M | -14.97M | -14.52M | -14.74M | -14.06M | -14.5M | -14.87M | -15.41M | -15.22M |